Legal Opinion
In re Fenofibrate Patent Litigation
District Court, S.D. New York
Decided December 27, 2012No. 11 MDL 2241(JSR)PublishedCited by 1 opinion
1Opinion of the Court
MEMORANDUM ORDER
JED S. RAKOFF, District Judge.
In this multi-district litigation, plaintiff Lupin Atlantis Holdings S.A. (“Lupin”), the owner of the approved New Drug Application for the prescription drug AN-TARA and the licensee of U.S. Patent No. 7,101,574 B1 (the “'574 patent”) and U.S. Patent No. 7,863,331 B2 (the “'331 patent”),1 alleges that defendants Mylan Inc. and Mylan Pharmaceuticals Inc. (collectively “Mylan”) and Apotex Inc. and Apotex Corp. (collectively “Apotex”) infringed both patents by seeking federal regulatory approval to manufacture generic versions of ANTARA.
The…
2Cases cited17 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Eli Lilly & Co. v. Medtronic, Inc.Supreme Court of the United States · 1990
- Phonometrics, Inc. v. Northern Telecom Inc., and United Telephone Company of Florida, and Sprint CorporationCourt of Appeals for the Federal Circuit · 1998
- Novartis Corporation v. Ben Venue Laboratories, Inc., and Bedford LaboratoriesCourt of Appeals for the Federal Circuit · 2001
12 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- In re Fenofibrate Patent LitigationDistrict Court, S.D. New York · 2013